Businesses and R&Ds
TWOCELLS aims to provide regenerative medicine as novel treatment options for patients with Unmet Medical Needs (UMN).
Businesses
To realize our management philosophy, we engage in the R&Ds, manufacturing and marketing of regenerative medicine and its related products.
R&Ds
TWOCELLS is conducting research and development to provide high-quality MSC products by applying originally developed cell culture technology using serum-free media.
As a typical example, gMSC®1 and other pipelines, are introduced on the following pages.
"gMSC®" represents “guaranteed” MSC, which is produced from allogeneic tissue using TWOCELLS’ originally developed serum-free media and culture technologies.
